CLINICAL USE OF INTERMEDIATE TO HIGH-DOSE OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN CHILDREN WITH ACUTE-LEUKEMIA

被引：2

作者：

TAKASHIMA, Y ^{[1
]}

机构：

[1] MEIJO HOSP,PEDIAT CLIN,FEDERAT NATL PUBL SERV PERSONNEL MUTUAL AID ASSOC,NAKA KU,NAGOYA 460,JAPAN

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 28卷 / 04期

关键词：

D O I：

10.1002/j.1552-4604.1988.tb03158.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：356 / 362

页数：7

共 50 条

[21] ANTIVIRAL EFFECT OF ANTILEUKEMIC DRUGS N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE (BH-AC) AND 2,2'-ANHYDRO-1-BETA-D-ARABINOFURANOSYLCYTOSINE (CYCLO-C) AGAINST HUMAN CYTOMEGALOVIRUS
NAKAMURA, K
EIZURU, Y
KUMURA, K
MINAMISHIMA, Y
JOURNAL OF MEDICAL VIROLOGY, 1990, 31 (02) : 141 - 147
[22] TREATMENT WITH HIGH-DOSE CYTOSTATICS - POSSIBILITIES OF USE IN ACUTE-LEUKEMIA
GASSMANN, W
SCHMITZ, N
KAYSER, W
LOFFLER, H
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, 112 (02) : 65 - 72
[23] HIGH-DOSE MERCAPTOPURINE FOLLOWED BY INTERMEDIATE-DOSE CYTARABINE IN RELAPSED ACUTE-LEUKEMIA
LOCKHART, S
PLUNKETT, W
JEHA, S
RAMIREZ, I
ZIPF, T
CORK, A
PINKEL, D
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (03) : 587 - 595
[24] MODULATION OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE METABOLISM BY THYMIDINE IN HUMAN ACUTE-LEUKEMIA
ZITTOUN, R
ZITTOUN, J
MARQUET, J
RUSTUM, Y
CREAVEN, P
CANCER RESEARCH, 1985, 45 (10) : 5186 - 5192
[25] EXPERIENCE WITH INTERMEDIATE AND HIGH-DOSE CYTOSINE-ARABINOSIDE IN REFRACTORY ACUTE-LEUKEMIA
WILLEMZE, R
FIBBE, WE
ZWAAN, FE
ONKOLOGIE, 1983, 6 (04): : 200 - 204
[26] SATURATION OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE 5'-TRIPHOSPHATE ACCUMULATION IN LEUKEMIA-CELLS DURING HIGH-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE THERAPY
PLUNKETT, W
LILIEMARK, JO
ADAMS, TM
NOWAK, B
ESTEY, E
KANTARJIAN, H
KEATING, MJ
CANCER RESEARCH, 1987, 47 (11) : 3005 - 3011
[27] PRELIMINARY-REPORT OF PHASE-I AND PHASE-II STUDY OF N4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE (BH-AC) IN PATIENTS WITH ACUTE-LEUKEMIA AND OTHER MALIGNANCIES
TANIMOTO, M
MINAMI, S
OHNO, R
KATO, Y
OGATA, K
MORISHIMA, Y
KAMIYA, T
KOBAYASHI, M
NISHIWAKI, H
YOSHIKAWA, S
YAMADA, K
TAKEYAMA, H
WATANABE, E
SUZUKI, H
TAKAMATSU, J
KAWASHIMA, K
YOSHIKAWA, H
KODERA, Y
EZAKI, K
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1978, 8 (02) : 153 - 159
[28] PLASMA AND CEREBROSPINAL-FLUID PHARMACOKINETICS OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE AND 1-BETA-D-ARABINOFURANOSYLURACIL FOLLOWING THE REPEATED INTRAVENOUS ADMINISTRATION OF HIGH-DOSE AND INTERMEDIATE-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE
DAMON, LE
PLUNKETT, W
LINKER, CA
CANCER RESEARCH, 1991, 51 (16) : 4141 - 4145
[29] PLASMA AND CEREBROSPINAL-FLUID PHARMACOKINETICS OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE AND 1-BETA-D-ARABINOFURANOSYLURACIL FOLLOWING THE REPEATED INTRAVENOUS ADMINISTRATION OF HIGH-DOSE AND INTERMEDIATE-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE
KREIS, W
BUDMAN, DR
CANCER RESEARCH, 1992, 52 (13) : 3818 - 3819
[30] 4-DEMETHOXYDAUNORUBICIN (IDARUBICIN) IN COMBINATION WITH 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN THE TREATMENT OF RELAPSED OR REFRACTORY ACUTE-LEUKEMIA
BERMAN, E
RAYMOND, V
DAGHESTANI, A
ARLIN, ZA
GEE, TS
KEMPIN, S
HANCOCK, C
WILLIAMS, L
STEVENS, YW
CLARKSON, BD
YOUNG, C
CANCER RESEARCH, 1989, 49 (02) : 477 - 481

← 1 2 3 4 5 →